BOSTON, April 15, 2015 /PRNewswire/ -- Silk Therapeutics, Inc., today announced the formation of its Physician Advisory Board, with the appointment of leading skincare experts, dermatologists and plastic surgeons. The Physician Advisory Board will be responsible for providing expert guidance as the company develops its luxury skincare lines for anti-aging and skin health applications based on Silk Therapeutics' proprietary silk technology platform.
"We are honored to have these distinguished physicians join our Advisory Board, sharing our vision to create skincare products based on the proven strength and protective benefits of pure silk," said Greg Altman, PhD, Chief Executive Officer, Silk Therapeutics. "Silk Therapeutics is grounded in clinical research and science. The expertise and guidance of these respected physicians will help us establish the benefits of silk protein technology in many aspects of skincare."
Members of the Silk Therapeutics Advisory Board:
Kenneth A. Arndt, MD, Clinical Professor of Dermatology, Emeritus, Harvard Medical School; Adjunct Professor at Brown and Dartmouth Medical Schools; and Partner, SkinCare Physicians, Chestnut Hill, MA; Author of Manual of Dermatologic Therapeutics, in its eighth edition
Mark Jewell, MD, Plastic Surgeon, Eugene, OR; Past President, American Society for Aesthetic Plastic Surgery; U.S. National Secretary, International Society for Aesthetic Plastic Surgery; Assistant Clinical Professor, Oregon Health Science University
Mario Lacouture, MD, Dermatologist, Associate Attending, Memorial Sloan Kettering Cancer Center, Associate Professor, Department of Dermatology, Cornell University, New York; Founding Chair, Skin Toxicity Study Group, Multinational Association of Supportive Care in Cancer; Physician of the Year 2012, CancerCare; Editor, Dermatologic Principles and Practice in Oncology; Author of Dr. Lacouture's Skin Care Guide for People Living With Cancer
Leonard Miller, MD, Plastic Surgeon, Boston, MA; Founder and Director, Boston Center for Facial Rejuvenation; Clinical Instructor in Surgery at Harvard Medical School; Staff Surgeon at Beth Israel Deaconess Hospital
David Rosenthal, MD, Oncologist, Dana Farber Cancer Institute, Boston, MA; Past Director, Zakim Center for Integrative Therapies; Past President, Society of Integrative Oncology; Past President, American Cancer Society; Professor, Harvard Medical School
Renato Saltz, MD, Plastic Surgeon, Salt Lake City, UT; Medical Director of Saltz Plastic Surgery & Medical Spa Vitoria and editor of Cosmetic Medicine & Aesthetic Surgery: Strategies for Success, QMP; 2009 President-elect, International Society of Aesthetic Plastic Surgery; Past President, American Society for Aesthetic Plastic Surgery; Founder & Chairman of The Image Reborn Foundation of Utah
Pure silk can enhance skin and also effectively surround, protect and deliver a range of treatments -- from vitamin C to therapeutic agents -- with potential applications in multiple healthcare, medical and consumer markets. By harnessing the power of real silk protein, unnecessary chemical additives and harmful preservatives are replaced with only a handful of carefully selected pure ingredients. Silk Therapeutics is currently developing an ultrasensitive skincare line designed as a pure, safe option for those with extremely sensitive skin, for conditions such as eczema, and for oncology patients undergoing chemotherapy and radiation, to heal, soothe and restore damaged and inflamed skin. "We will look to our Physician Advisory Board members, including one of the leading academic clinicians in dermatology, Dr. Kenneth Arndt, and noted plastic surgeons, Drs. Jewell, Miller and Saltz, to guide our efforts in developing products suitable for medically relevant skin treatments," added Altman. "Our skincare line is designed to serve as one of the cleanest options for our customers who refuse to compromise between beauty and health, as well as women who are either nursing or pregnant, and patients undergoing chemotherapy and radiation," added Altman. "We are especially pleased to work with Drs. Rosenthal and Lacouture, two noted experts in integrative medicine and oncology skincare, to address the unmet skincare needs of this patient population."
The company's proprietary silk technology creates a pure, liquid silk solution to support skin health and fight the signs of aging by locking in moisture, smoothing fine lines and wrinkles, and protecting the skin. Silk Therapeutics is the only skincare line produced from pure, natural silk protein, rather than silk waste byproducts such as hydrolyzed silk, sericin, silk powder or genetically modified proteins.
The founders of Silk Therapeutics, Altman and Rebecca Horan, PhD, the company's Chief Operating Officer, are biomedical engineers world-renowned for pioneering silk science to improve human health. They have worked together for more than 15 years, developing silk-based platform technologies for applications in diverse medical specialties, including orthopedics, plastic surgery, general surgery and women's health.
Silk Therapeutics' consumer product line is sold online at www.silktherapeutics.com.
About Silk Therapeutics
Silk Therapeutics, Inc., headquartered in Boston, MA, is the leader in silk protein solutions for human health and wellness. The founders of Silk Therapeutics are world-renowned as pioneers in silk science to improve human health. Dr. Greg Altman, CEO, and Dr. Rebecca Horan, Chief Operating Officer, have worked together for more than 15 years developing silk-based applications used in a number of medical products, and are currently focused on addressing unmet needs in the treatment and enhancement of skin. Dr. Horan's personal experience as a cancer survivor, and the company's commitment to the wellbeing of its customers, is the foundation for Silk Therapeutics pure, risk-free skincare that works naturally with the body.
SOURCE Silk Therapeutics, Inc.